Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 217

The potential for a value revival

The Danish philosopher Søren Kierkegaard observed that, “Life can only be understood backward, but it must be lived forward.” With the benefit of hindsight, events of the past often seem rational, even inevitable, yet the present is always fraught with uncertainty. This could also be said about investing.

Today’s investment climate could be summed up as cautious and noticeably bereft of conviction. While global equity markets have more than doubled from GFC lows, investors remain concerned about central bank policies, currencies and commodities, among other issues.

Even so, our company’s conviction in value investing is strengthening as we try to “understand the market backwards”.

What is value investing?

Value investing is a strategy where stocks are selected that trade for less than their intrinsic values. Value investors seek out stocks they believe the market has undervalued. These differ from growth stocks, which are companies whose earnings are expected to grow at an above-average rate relative to the market.

Value investors believe the market overreacts to good and bad news, resulting in stock price movements that do not correspond with a company's long-term fundamentals, giving an opportunity to profit when the price is deflated.

Valuation gap is extreme

Value stocks remain historically cheap relative to growth stocks. In fact, the valuation gap between value and growth stocks on a Price to Book value (P/BV) is at an extreme not seen for some time (see chart below).

Investors would have to go back to the height of the ‘dotcom bubble’ in 2000 to find such extremes. Back then, interest in tech stocks was enormous, based on their perceived growth potential. Today, it is the consumer staples sector that is attracting market focus as investors look for growth stocks that offer the perception of safety and stability in an uncertain environment.

Value on the rebound

One of the stronger catalysts for a value revival is rising interest rates. In the past, value cycles have occurred when rising interest rates have corresponded with a strengthening economy, although some argue it is the stronger economy and inflationary pressures that were the real drivers of the value revival. Today, however, global economic growth is moderate and deflationary pressures persist.

While value can be pro-cyclically correlated to the economy, this isn’t always the case. For example, investors waiting for an improving economic cycle would have missed the value upturn in 2000. Investors fleeing value in anticipation of economic weakness would have missed value’s outperformance during the recession of 1981-82. In each of these instances, we believe stocks simply became too cheap and a reversion to the mean prompted a value rally.

Rather than economic growth, we consider valuation of stocks a far more accurate predictor of future returns and a value recovery. When it comes to value, today’s valuation starting point is distinctly compelling.

Value moving beyond 'the usual suspects'

Since the GFC, value stocks have been primarily concentrated in either the resource sectors such as energy and materials or rate-sensitive sectors such as financials. For many, being a value investor has therefore meant taking on commodity risk or interest rate risk.

Recently, however, value has proliferated beyond just a few deep cyclical sectors to across the broad market. For example, value is just as cheap today within pharmaceuticals and biotechs as it is within financials and energy, as shown in the chart below.

The long-term trends for pharma and biotechs are encouraging given the ageing world population and increased wealth in emerging markets. Regulatory reform and drug pricing are clouds hanging over the industry but will not impact all companies in the same way. The best way to deal with a tough price environment is to innovate. We are invested in companies working on drugs for immune-oncology, gene therapy and Alzheimer’s which have huge potential. Current concern and uncertainty is allowing us to buy new stocks at what we believe to be a discount, and this is where the advantage of having a long-term horizon and patience comes in.

Long term view helps pick a bargain

Uncertainty is a fact of life and the road ahead is rarely obvious. One way to deal with uncertainty is taking a longer-term investment horizon. Many of the macro and political variables that drive markets in the short term are unforecastable with any reliable degree of certainty. However, long term valuations move reliably through cycles, as do economic variables like commodity prices and interest rates. Quantifying the potential impact of different scenarios on each of our holdings’ prospects and earnings and contrasting them with the company’s valuation allows us to judge whether we have identified a value bargain.

 

Peter Wilmshurst is Portfolio Manager of Templeton Global Growth Fund Ltd (ASX:TGG) plus a number of Templeton Global Equity Group's global portfolios. This article is general information and does not consider the needs of any individual.


 

Leave a Comment:

RELATED ARTICLES

Reece Birtles on selecting stocks for income in retirement

Inflation: friend or foe of Value stocks in 2022?

The growth outperformance myth

banner

Most viewed in recent weeks

Australian house prices close in on world record

Sydney is set to become the world’s most expensive city for housing over the next 12 months, a new report shows. Our other major cities aren’t far behind unless there are major changes to improve housing affordability.

The case for the $3 million super tax

The Government's proposed tax has copped a lot of flack though I think it's a reasonable approach to improve the long-term sustainability of superannuation and the retirement income system. Here’s why.

Tariffs are a smokescreen to Trump's real endgame

Behind market volatility and tariff threats lies a deeper strategy. Trump’s real goal isn’t trade reform but managing America's massive debts, preserving bond market confidence, and preparing for potential QE.

The super tax and the defined benefits scandal

Australia's superannuation inequities date back to poor decisions made by Parliament two decades ago. If super for the wealthy needs resetting, so too does the defined benefits schemes for our public servants.

Meg on SMSFs: Withdrawing assets ahead of the $3m super tax

The super tax has caused an almighty scuffle, but for SMSFs impacted by the proposed tax, a big question remains: what should they do now? Here are ideas for those wanting to withdraw money from their SMSF.

Getting rich vs staying rich

Strategies to get rich versus stay rich are markedly different. Here is a look at the five main ways to get rich, including through work, business, investing and luck, as well as those that preserve wealth.

Latest Updates

SMSF strategies

Meg on SMSFs: Withdrawing assets ahead of the $3m super tax

The super tax has caused an almighty scuffle, but for SMSFs impacted by the proposed tax, a big question remains: what should they do now? Here are ideas for those wanting to withdraw money from their SMSF.

Superannuation

The huge cost of super tax concessions

The current net annual cost of superannuation tax subsidies is around $40 billion, growing to more than $110 billion by 2060. These subsidies have always been bad policy, representing a waste of taxpayers' money.

Planning

How to avoid inheritance fights

Inspired by the papal conclave, this explores how families can avoid post-death drama through honest conversations, better planning, and trial runs - so there are no surprises when it really matters.

Superannuation

Super contribution splitting

Super contribution splitting allows couples to divide before-tax contributions to super between spouses, maximizing savings. It’s not for everyone, but in the right circumstances, it can be a smart strategy worth exploring.

Economy

Trump vs Powell: Who will blink first?

The US economy faces an unprecedented clash in leadership styles, but the President and Fed Chair could both take a lesson from the other. Not least because the fiscal and monetary authorities need to work together.

Gold

Credit cuts, rising risks, and the case for gold

Shares trade at steep valuations despite higher risks of a recession. Amid doubts that a 60/40 portfolio can still provide enough protection through times of market stress, gold's record shines bright.

Investment strategies

Buffett acolyte warns passive investors of mediocre future returns

While Chris Bloomstan doesn't have the track record of his hero, it's impressive nonetheless. And he's recently warned that today has uncanny resemblances to the 1990s tech bubble and US returns are likely to be disappointing.

Sponsors

Alliances

© 2025 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.